Through their ability to negatively regulate the PI3K-AKT, p70/p85 S6K, ERK/MAP kinase, and the c-MYC pathways, methylation-sensitive PP2A enzymes are thought to act as tumor-suppressors, whose downregulation/mutation promotes tumorigenesis17. The gene discussed is MYC; the disease is neoplasm.